| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910465419203321 |
|
|
Autore |
Savit͡skiĭ A. P. |
|
|
Titolo |
Sintering of systems with interacting components / / A.P. Savitskii |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Stafa-Zuerich ; ; United Kingdom : , : Trans Tech, , [2009] |
|
©2009 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (292 p.) |
|
|
|
|
|
|
Collana |
|
Materials science foundations, , 1422-3597 ; ; volumes 57-58 |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Sintering |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Based on the earlier work : Liquid phase sintering of the systems with interacting components. |
|
|
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
Sintering of Systems with Interacting Components; Arnold Savitskii ; Brief Annotation; Preface to the English Edition; Preface to the Russian Edition; Introduction; Table of Contents; Table of Contents; CHAPTER 1. SINTERING OF SINGLE PHASES; 1.1. Mechanisms of Sintering; 1.2. Factors Affecting Sintering; CHAPTER 2. PRINCIPAL AND RELATED PROBLEMS; 2.1. Driving Forces for Sintering; Definition of the Term "Sintering"; 2.2. Diffusion Interaction between Solid and Liquid Metals; 2.3. Plastic Flow in the Diffusion Zone; 2.4. Growth of Powder Compacts during Liquid-Phase Sintering |
2.5. Dilatometry of Powder Compacts during Liquid-Phase Sintering2.6. Formation of Liquid Phase in Systems with Intermetallic Compounds; CHAPTER 3. VOLUME CHANGES OF TWO-COMPONENT COMPACTS DURING SINTERING; 3.1 Model of Two-Component Powder Compact Being Sintered in the Solid State; 3.2. Volume Changes of Ti-Ni Powder Compacts during Sintering; 3.3. Model of Powder Compact Being Sintered in the Presence of a Liquid Phase; 3.4. Amount of Growth of Powder Compacts during Liquid-Phase Sintering; 3.5. Degree of Densification of Compacts during Liquid-Phase Sintering |
3.6. Overall Magnitude of Compact Volume Changes during Liquid-Phase SinteringCHAPTER 4. SINTERING OF SYSTEMS WITH CONSIDERABLE SOLUBILITY IN THE SOLID PHASE; 4.1. Effect of Titanium Particle Size on Compact Growth in the Ti-Al System; 4.2. Dilatometric |
|
|
|
|
|
|
|
|
|
|
|
and Structural Studies of Growth Process in the Ti-Al System; 4.3. Volume Growth as a Method for Obtaining Highly Porous Ti-Al Alloys; 4.4. Volume Changes Exhibited by Al-Zn Compacts; 4.5. Liquid-Phase Sintering of Powder Compacts in the Al-Mg System; CHAPTER 5. SYSTEMS WITH CONSIDERABLE SOLUBILITY OF THE COMPONENTS IN THE SOLID AND LIQUID |
5.1. Volume Changes of Compacts in the Cu-Sn System5.2. Dilatometric and Structural Studies of Liquid-Phase Sintering in the Cu-Sn System; 5.3. Volume Changes in Cu-Al Compacts; 5.4. Aluminium Bronze, Parts made from which Change Little in Size during Sintering; CHAPTER 6. Al-Cu SYSTEM WITH HIGH SOLUBILITY IN THE LIQUID PHASE; 6.1. Volume Changes of Al-Cu Compacts during Sintering; 6.2. Effect of Porosity upon Volume Changes; 6.3. Effect of Aluminium Particle Size; 6.4. Alloy and Structure Formation; 6.5. Sintering in the Presence of a Large Amount of Liquid Phase; 6.6. Exothermal Sintering |
6.7. Optimisation of Liquid-Phase Sintering Regimes6.8. Possibility of Decreasing Compact Growth during Sintering; CHAPTER 7. SINTERING OF ALUMINIUM WITH TRANSITION METALS; 7.1. Liquid-Phase Sintering of the Al-Cr System; 7.2. Liquid-Phase Sintering of the Al-Ti System; 7.3. Liquid-Phase Sintering of the Al-Ni System; 7.4. Liquid-Phase Sintering of the Al-Fe System; CONCLUSION; References |
|
|
|
|
|
|
Sommario/riassunto |
|
The aim of this publication is to acquaint those readers who are interested in the fundamentals of powder materials sintering, with the latest scientific achievements which are important to its successful practice. The book contains new information, not previously known in the West, as well as offering a totally fresh view of this vital issue. The work discloses to western eyes a new scientific trend in the science of sintering systems with interacting components; a trend of which many experts are unaware. The new approach will considerably enrich and advance investigations into the theory and |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910463779103321 |
|
|
Titolo |
Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York, New York : , : Demos Medical, , 2015 |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (369 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Botulinum toxin - Therapeutic use |
Injections |
Nervous system - Diseases - Treatment |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Cover; Title; Copyright; Contents; Contributors; Preface; Share Botulinum Neurotoxin Injection Manual; Section One: Botulinum Neurotoxin: Basic Science and Reconstitution; Chapter 1: Pharmacology of Botulinum Neurotoxins; Normal Neurotransmitter Release; BoNTs Synthesis and Structure; BoNT Binding/Blocking; BoNT Potency and Dosing; Clinical Implications of BoNT Pharmacology; Antigenicity, Antibody Formation, and Nonresponsiveness to BoNT; Safety; Central Effects of BoNTs; Summary; Chapter 2: Comparison of Botulinum Neurotoxin Products; BoNT Approvals |
BoNT Products: Antigenicity, Dilution, and DiffusionBoNT Products: Potency and Dose; Converting Units/Dose Among BoNT Products; Summary; Chapter 3: Neurotoxin Storage, Reconstitution, Handling, and Dilution; Serotype B BoNT; Serotype A BoNTs; OnabotulinumtoxinA (Botox®) Reconstitution and Handling; AbobotulinumtoxinA (Dysport®) Reconstitution and Handling; IncobotulinumtoxinA (Xeomin®) Reconstitution and Handling; RimabotulinumtoxinB (Myobloc® in the United States, NeuroBloc® Outside the United States) Reconstitution and Handling; Injection Supplies; Needle Selection |
Chapter 4: Guidance Techniques for Botulinum Neurotoxin |
|
|
|
|
|
|
|
|
|
|
|
InjectionsAnatomic Reference Guides, Surface Anatomy, and Palpation Guidance; EMG Guidance; Electrical Stimulation Guidance; B-Mode Ultrasound; Combinations of Techniques; Other Guidance Techniques for BoNT Injections; Summary; Chapter 5: Phenol Nerve Blocks; Why Consider Phenol Neurolysis?; Phenol Mechanism of Action; Muscle Hypertonia; Pattern of Involvement; Injection Technique and Dosing; Musculocutaneous Nerve; Obturator Nerve; Tibial Motor Nerves; Summary; Section Two: Clinical Applications of Botulinum Neurotoxins |
Part I: Botulinum Neurotoxins for the Treatment of Muscle Overactivity Associated with Focal Dystonia Syndromes and Upper Motor Neuron SyndromesCraniofacial Dystonia; Chapter 6: Benign Essential Blepharospasm; Chapter 7: Botulinum Neurotoxin Therapy for Hemifacial Spasm; Chapter 8: Botulinum Neurotoxin Injections for Oromandibular Dystonias; Illustrations for Craniofacial Dystonia; Cervical Dystonia; Chapter 9: Botulinum Neurotoxin Injections for Cervical Dystonia; Illustrations for Cervical Dystonia; Upper Limb, Lower Limb, and Trunk Dystonia |
Chapter 10: Botulinum Neurotoxin for the Treatment of Idiopathic Primary Focal Limb DystoniaChapter 11: Botulinum Neurotoxin for Treatment of Muscle Overactivity Associated with Upper Motor Neuron Syndromes; Chapter 12: Botulinum Neurotoxin for the Treatment of Trunk Dystonia/Camptocormia; Chapter 13: Botulinum Neurotoxin Injections for the Treatment of Tremor; Illustrations for Upper Limb, Lower Limb, and Trunk Dystonia; Part II: Botulinum Neurotoxins for Neurosecretory Disorders; Chapter 14: Botulinum Neurotoxin Therapy for Problematic Sialorrhea; Condition |
Chapter 15: Botulinum Neurotoxin Therapy for Hyperhidrosis |
|
|
|
|
|
|
Sommario/riassunto |
|
The Essential Guide for Clinicians Who Prescribe and Inject BoNTs. This is a detailed and practical guide to botulinum neurotoxin therapy (BoNT) and the wide range of applications for neurological and pain disorders. A unique reference source for new injectors and experienced clinicians alike, this indispensable manual provides information on dose, dilution, and indications for all four FDA-approved toxins in one handy text. Following a brief review of relevant pharmacology, the book provides product information and comparative distinctions between the four FDA-approved toxins (Botox , Myobloc |
|
|
|
|
|
|
|
| |